Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jared Watkin currently holds 71,366 shares of ABBOTT LABORATORIES (ABT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jared Watkin has been a net seller of ABT stock. They have purchased $0 and sold $42.0M worth of shares.
Jared Watkin's most recent insider trade was on Mar 1, 2023, when they sold 1,198 shares at $100.70 per share.
Jared Watkin serves as Executive at ABBOTT LABORATORIES (ABT). They have executed 63 insider transactions totaling $42.0M over their tenure at the company.
Jared Watkin holds the position of Executive at ABBOTT LABORATORIES, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Jared Watkin has shown a selling trading pattern, with $0 in total purchases and $42.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jared Watkin was on May 2, 2019, when they sold $24.3M worth of ABT shares. This transaction involved 309,429 shares at $78.51 per share.
Jared Watkin currently owns 71,366 shares of ABBOTT LABORATORIES (ABT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jared Watkin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jared Watkin has 63 Form 4 filings on record as an insider at ABBOTT LABORATORIES.
Set alerts for Jared Watkin and 40,000+ other insiders.